|
|
|
|
|
|
|
M T Wed Th F |
|
20 May, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
Some diseases set children on a damaging path before birth, which has researchers looking at editing the genes of fetuses in utero. But that's not so far from editing an embryo's genes, an act that sent the scientific world into a tizzy when a Chinese researcher did it in 2018. Ryan Cross reports on that shifting red line. |
|
|
|
Karen Weintraub |
Deputy Editor, Endpoints News
|
|
|
|
 |
| . |
 |
|
|
|
by Ryan Cross
|
BOSTON— Over the past year, I’ve begun hearing rumblings from scientists who secretly think it’s time to stop being stodgy about editing the genes... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
💉 Pfizer’s experimental 25-valent pneumococcal shot beats Prevnar 20: The vaccine candidate, codenamed PF-07872412, produced higher geometric mean titers for serotype 3 than Pfizer’s... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Parabilis Medicines, the decade-old and well-funded "undruggable" biotech out of Greg Verdine's Harvard lab, seeks to become the 12th drug developer to conduct an... | |
|
|
|
|
|
|
|
|
by Reynald Castaneda, Anna Brown
|
European healthcare investor GHO Capital and asset management firm CBC Group are set to join forces, with the new entity to manage over $21 billion... | |
|
|
|
|
|
